BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33060122)

  • 1. Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice.
    Montay-Gruel P; Acharya MM; Gonçalves Jorge P; Petit B; Petridis IG; Fuchs P; Leavitt R; Petersson K; Gondré M; Ollivier J; Moeckli R; Bochud F; Bailat C; Bourhis J; Germond JF; Limoli CL; Vozenin MC
    Clin Cancer Res; 2021 Feb; 27(3):775-784. PubMed ID: 33060122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the neurological mechanism of the FLASH effect in juvenile mice exposed to hypofractionated radiotherapy.
    Allen BD; Alaghband Y; Kramár EA; Ru N; Petit B; Grilj V; Petronek MS; Pulliam CF; Kim RY; Doan NL; Baulch JE; Wood MA; Bailat C; Spitz DR; Vozenin MC; Limoli CL
    Neuro Oncol; 2023 May; 25(5):927-939. PubMed ID: 36334265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
    Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
    Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of radiation fractionation regimens on glioblastoma.
    McKelvey KJ; Hudson AL; Donaghy H; Stoner SP; Wheeler HR; Diakos CI; Howell VM
    Radiat Oncol; 2022 Jan; 17(1):17. PubMed ID: 35073960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.
    Montay-Gruel P; Acharya MM; Petersson K; Alikhani L; Yakkala C; Allen BD; Ollivier J; Petit B; Jorge PG; Syage AR; Nguyen TA; Baddour AAD; Lu C; Singh P; Moeckli R; Bochud F; Germond JF; Froidevaux P; Bailat C; Bourhis J; Vozenin MC; Limoli CL
    Proc Natl Acad Sci U S A; 2019 May; 116(22):10943-10951. PubMed ID: 31097580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncovering the Protective Neurologic Mechanisms of Hypofractionated FLASH Radiotherapy.
    Alaghband Y; Allen BD; Kramár EA; Zhang R; Drayson OGG; Ru N; Petit B; Almeida A; Doan NL; Wood MA; Baulch JE; Ballesteros-Zebadua P; Vozenin MC; Limoli CL
    Cancer Res Commun; 2023 Apr; 3(4):725-737. PubMed ID: 37377749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term anti-tumor effects following both conventional radiotherapy and FLASH in fully immunocompetent animals with glioblastoma.
    Liljedahl E; Konradsson E; Gustafsson E; Jonsson KF; Olofsson JK; Ceberg C; Redebrandt HN
    Sci Rep; 2022 Jul; 12(1):12285. PubMed ID: 35853933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-High-Dose-Rate FLASH Irradiation Limits Reactive Gliosis in the Brain.
    Montay-Gruel P; Markarian M; Allen BD; Baddour JD; Giedzinski E; Jorge PG; Petit B; Bailat C; Vozenin MC; Limoli C; Acharya MM
    Radiat Res; 2020 Dec; 194(6):636-645. PubMed ID: 32853387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. News FLASH-RT: To Treat GBM and Spare Cognition, Fraction Size and Total Dose Matter.
    Huang CC; Mendonca MS
    Clin Cancer Res; 2021 Feb; 27(3):662-664. PubMed ID: 33268551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System.
    Diffenderfer ES; Verginadis II; Kim MM; Shoniyozov K; Velalopoulou A; Goia D; Putt M; Hagan S; Avery S; Teo K; Zou W; Lin A; Swisher-McClure S; Koch C; Kennedy AR; Minn A; Maity A; Busch TM; Dong L; Koumenis C; Metz J; Cengel KA
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):440-448. PubMed ID: 31928642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Effect by Either FLASH or Conventional Dose Rate Irradiation Involves Equivalent Immune Responses.
    Almeida A; Godfroid C; Leavitt RJ; Montay-Gruel P; Petit B; Romero J; Ollivier J; Meziani L; Sprengers K; Paisley R; Grilj V; Limoli CL; Romero P; Vozenin MC
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):1110-1122. PubMed ID: 37951550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-high-dose-rate FLASH and Conventional-Dose-Rate Irradiation Differentially Affect Human Acute Lymphoblastic Leukemia and Normal Hematopoiesis.
    Chabi S; To THV; Leavitt R; Poglio S; Jorge PG; Jaccard M; Petersson K; Petit B; Roméo PH; Pflumio F; Vozenin MC; Uzan B
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):819-829. PubMed ID: 33075474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?
    Cengel KA; Kim MM; Diffenderfer ES; Busch TM
    Semin Radiat Oncol; 2024 Apr; 34(2):218-228. PubMed ID: 38508786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection of Radiosensitive Juvenile Mice by Ultra-High Dose Rate FLASH Irradiation.
    Alaghband Y; Cheeks SN; Allen BD; Montay-Gruel P; Doan NL; Petit B; Jorge PG; Giedzinski E; Acharya MM; Vozenin MC; Limoli CL
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32599789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of hypofractionated radiotherapy in treatment of glioblastoma multiforme in elderly patients not receiving adjuvant chemoradiotherapy: A National Cancer Database Analysis.
    Bingham B; Patel CG; Shinohara ET; Attia A
    J Neurooncol; 2018 Jan; 136(2):385-394. PubMed ID: 29209874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External beam radiation dose escalation for high grade glioma.
    Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
    Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of Tight Junction Integrity in the Absence of Vascular Dilation in the Brain of Mice Exposed to Ultra-High-Dose-Rate FLASH Irradiation.
    Allen BD; Acharya MM; Montay-Gruel P; Jorge PG; Bailat C; Petit B; Vozenin MC; Limoli C
    Radiat Res; 2020 Dec; 194(6):625-635. PubMed ID: 33348373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.